Sometransactions are about market share, synergies and valuations. Others gofurther and create an immediate benefit for society. The strategic investmentby Nasdaq-listed US medical technology company TransMedics Group, Inc. (Nasdaq:TMDX) in PAD Aviation Service GmbH clearly belongs in the second category. Itlays the foundation for the first dedicated European air and ground logisticsnetwork for organ transplantation – an undertaking that can ultimately helpsave lives.
The Middelhoff Groupadvised PAD Aviation throughout this process and supported the negotiations throughto a successful close.
After theplanned investment was first announced in April 2026, the transaction has nowbeen successfully completed. TransMedics, a global leader in portableextracorporeal warm perfusion and the assessment of donor organs, is making astrategic investment in one of Europe's leading business aviation operators.
The purpose ofthe investment goes well beyond a classic capital participation. Together, thetwo companies intend to build a pan-European logistics network for organtransplantation. The goal is to replicate TransMedics' already successful USOCS NOP model in Europe, expand the adoption of OCS perfusion technology, andsupport transplant activity across the entire European Union. At its core, theambition is to broaden access to donor organs and increase the number ofsuccessful transplants for patients throughout Europe.
In transplantmedicine, time is the single most critical factor. The window between theretrieval of a donor organ and the transplant itself is narrow, and everyminute counts. This is precisely where the collaboration between the twocompanies comes in.
With its OCS(Organ Care System) technology, TransMedics has developed a solution that keepsdonor organs outside the body in a warm, perfused state, preserving theirquality and allowing their viability to be assessed prior to transplantation.This not only extends the available time window but also has the potential toincrease the number of usable donor organs for the treatment of end-stageheart, lung and liver failure. Headquartered in Andover, Massachusetts, thecompany was founded to address the unmet need for organs for transplantation.
What makes thistechnology effective at scale is the right logistics, and that is where PADAviation comes in.
Founded in2006, PAD Aviation looks back on a 20-year history in private aviation andoperates independently of commercial airlines. From its 24/7 hub in Paderborn,the company offers maximum flexibility, a quality that makes all the differencefor time-critical missions such as organ transport.
With a modernfleet and more than 40 highly qualified, type-rated pilots, PAD Aviation hasexactly the operational substance that a dedicated European transplant networkrequires. It is on this foundation that a network is now being built togetherwith TransMedics, one designed to reliably connect clinics and transplant centersacross Europe.
The Middelhoff Groupadvised PAD Aviation throughout the entire process and supported thenegotiations through to completion. At the center of our mandate was securingan economically optimal and structurally sound transaction for PAD Aviation,from strategic positioning and negotiation to a successful closing.
For us, thisdeal is a prime example of what the Middelhoff Group stands for: strategicvision, entrepreneurial thinking and hands-on execution, combined with aninternational network that guides companies safely through pivotal moments intheir development.
This closing isfirst and foremost a success for our client. We warmly congratulate the entirePAD Aviation team on this milestone in the company's history, and we thank themfor the trust they placed in us.
A 20-yearhistory in business aviation now turns a new page, one in which PAD Aviation,together with a strong international partner, is building a European networkthat can help save lives. We are proud to have been part of this journey andlook forward to everything that lies ahead for PAD Aviation.
.png)
.jpg)